利索-全球专利检索

  1. 登录
  2. 注册

搜索结果

102 条记录 (耗时 0.018 秒)

    BLOOD ANALYZER
    7.
    发明公开
    BLOOD ANALYZER 审中-公开
    BLUTANALYSATOR

    公开(公告)号：EP2926732A1

    公开(公告)日：2015-10-07

    申请号：EP15160051.7

    申请日：2015-03-20

    申请人： SYSMEX CORPORATION

    发明人： Abe, Masaki ,  Tsuji, Tomohiro

    IPC分类号： A61B5/157 ,  G01N15/14 ,  G01N33/49

    CPC分类号： G01N33/5094 ,  G01N15/1459 ,  G01N33/492 ,  G01N33/56972 ,  G01N33/721 ,  G01N33/80 ,  G01N2800/222 ,  G01N2800/224

    摘要： A blood analyzer is provided that comprises: a measurement unit that measures a blood sample and output measurement data; a controller that analyzes the measurement data outputted from the measurement unit, generates analysis data on each of blood cell types including red blood cell, white blood cell, and platelet, and generates support information for discriminating a cause of a reduction in the number of blood cells of a predetermined type among the blood cell types from analysis data including first analysis data on the predetermined blood cell type and second analysis data on a blood cell type other than the predetermined blood cell type; and an output unit that outputs the support information.

    摘要翻译： 提供一种血液分析装置，包括：测量单元，测量血样并输出测量数据; 分析从测量单元输出的测量数据的控制器，产生包括红细胞，白细胞和血小板在内的每种血细胞类型的分析数据，并产生用于鉴别血液数量减少的原因的支持信息 来自分析数据的预定类型的细胞，包括关于预定血细胞类型的第一分析数据和除了预定血细胞类型之外的血细胞类型的第二分析数据; 以及输出单元，输出支持信息。

    PLATELET ANALYSIS SYSTEM
    8.
    发明公开
    PLATELET ANALYSIS SYSTEM 审中-公开
    滑动系统分析

    公开(公告)号：EP2665830A4

    公开(公告)日：2014-09-03

    申请号：EP12834174

    申请日：2012-01-19

    申请人： TOMER AARON

    发明人： TOMER AARON

    IPC分类号： A61K31/727 ,  G01N33/569 ,  G01N33/86

    CPC分类号： G01N33/86 ,  G01N33/56966 ,  G01N2333/70557 ,  G01N2800/222

    摘要： A method for diagnosis of HIT (Heparin-induced thrombocytopenia) in a patient's serum or plasma sample and a system comprising kits for performing the method are provided, where the method involves incubating a patient's sample with and without heparin and normal control sample with and without heparin with a platelet-rich plasma (PRP) of an individual not having a platelet disorder and then incubating an aliquot of each sample with a first label for both heparin activated and non-heparin activated platelets and a second label for platelets activated by the heparin-immune complex formed in the patient sample. HIT is diagnosed when the difference between the amount of activated platelets from the patient's sample with and without heparin is substantially larger than the difference between the normal control sample with and without heparin.